Lemaitre Vascular (LMAT) Return on Capital Employed (2011 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Return on Capital Employed of 12.4% for Q1 2026, up 238.0% year-over-year from 3.67% in Q1 2025, and up 4.17% quarter-over-quarter from 11.9% in Q4 2025.
Lemaitre Vascular (LMAT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Return on Capital Employed for 16 consecutive years, with 12.4% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 238.0% year-over-year to 12.4%; the TTM figure through Mar 2026 stood at 12.4% (up 238.0% YoY), while the FY2025 annual figure was 12.41%, down 8.0% from the prior year.
- Return on Capital Employed grew to 12.4% in Q1 2026 per LMAT's latest filing, from 11.9% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 14.56% in Q3 2024 and bottomed at 9.27% in Q1 2023.
- Historically, Return on Capital Employed has averaged 11.5% across 5 years, with a median of 11.41% in 2022.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 572 bps — and 2024, when it jumped 345 bps.
- Lemaitre Vascular's Return on Capital Employed stood at 9.55% in 2022, then grew by 24 bps to 11.82% in 2023, then gained by 2 bps to 12.05% in 2024, then retreated by 1 bps to 11.9% in 2025, then grew by 4 bps to 12.4% in 2026.
- Business Quant data shows LMAT's Return on Capital Employed at 12.4% in Q1 2026, 11.9% in Q4 2025, and 11.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.69 Bn | 129.47 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.58 Bn | 51.71 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.75 Bn | 34.39 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.89 Bn | 32.42 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.13 Bn | 26.45 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.40 Bn | 14.99 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.84 Bn | 14.70 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 3.28% |
| 10 | Lemaitre Vascular | 1.89 Bn | 1.51 Bn | 50.76 Mn | 12.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.78% |
| Mar 31, 2026 | 12.40% |
| Dec 31, 2025 | 11.90% |
| Sep 30, 2025 | 11.17% |
| Jun 30, 2025 | 10.22% |
| Mar 31, 2025 | 10.02% |
| Dec 31, 2024 | 12.05% |
| Sep 30, 2024 | 14.56% |
| Jun 30, 2024 | 13.70% |
| Mar 31, 2024 | 12.58% |
| Dec 31, 2023 | 11.82% |
| Sep 30, 2023 | 11.11% |
| Jun 30, 2023 | 10.33% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 9.55% |
| Sep 30, 2022 | 10.16% |
| Jun 30, 2022 | 11.41% |
| Mar 31, 2022 | 13.27% |
| Dec 31, 2021 | 13.52% |
| Sep 30, 2021 | 15.32% |